$12.19 0.3%
NEOG Stock Price vs. AI Score
Data gathered: December 26

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Neogen (NEOG)

Analysis generated February 29, 2024. Powered by Chat GPT.

Neogen Corporation is a high-growth company that provides a diverse range of solutions for food and animal safety. It designs, manufactures, and markets a suite of products dedicated to ensuring the safety and quality of food and pharmaceuticals, along with maintaining health and nutritional standards in animals. The demand for such safety measures is continuously on the rise in response to increasing global health awareness and stringent regulatory environments. Neogen serves a growing market bookended by consumers increasingly interested in transparency regarding food sources and production practices.

Read full AI stock Analysis

Stock Alerts - Neogen (NEOG)

company logo Neogen | December 19
Price is up by 5.5% in the last 24h.
company logo Neogen | December 9
Price is up by 5.2% in the last 24h.
company logo Neogen | December 5
Price is down by -5.2% in the last 24h.
company logo Neogen | December 3
Price is down by -5.1% in the last 24h.

About Neogen

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide.


Neogen
Price $12.19
Target Price Sign up
Volume 318,680
Market Cap $2.65B
Year Range $11.61 - $17.71
Dividend Yield 0%
PE Ratio 865
Analyst Rating 0% buy
Earnings Date January 9 '25
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24434M210M105M-13M33M0.070
Q1 '24447M236M117M-2M28M0.120
Q4 '23449M233M117M-3.5M30M0.110
Q3 '23450M227M117M1.5M36M0.110
Q2 '23471M237M123M5.6M41M0.140

Insider Transactions View All

ADENT JOHN EDWARD filed to buy 216,477 shares at $13.8.
October 15 '24
Tobin James P filed to buy 23,392 shares at $16.9.
August 7 '24
Jones Douglas Edward filed to buy 46,131 shares at $12.4.
April 17 '24
BOREL JAMES C filed to buy 21,392 shares at $13.1.
April 11 '24
ADENT JOHN EDWARD filed to buy 152,389 shares at $12.4.
April 10 '24

What is the Market Cap of Neogen?

The Market Cap of Neogen is $2.65B.

What is Neogen's PE Ratio?

As of today, Neogen's PE (Price to Earnings) ratio is 865.

When does Neogen report earnings?

Neogen will report its next earnings on January 9 '25.

What is the current stock price of Neogen?

Currently, the price of one share of Neogen stock is $12.19.

How can I analyze the NEOG stock price chart for investment decisions?

The NEOG stock price chart above provides a comprehensive visual representation of Neogen's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Neogen shares. Our platform offers an up-to-date NEOG stock price chart, along with technical data analysis and alternative data insights.

Does NEOG offer dividends to its shareholders?

As of our latest update, Neogen (NEOG) does not offer dividends to its shareholders. Investors interested in Neogen should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Neogen?

Some of the similar stocks of Neogen are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.